Netherlands-based biotechnology company Mevaldi B.V. announced that it has secured new funding led by ICOS Capital, with continued support from existing investors High-Tech Gründerfonds (HTGF) and ICIG Ventures. Mevaldi focuses on developing sustainable chemical building blocks for polymers and polyurethanes using renewable biological raw materials.
Bio-Based Chemicals from Sugars and Wood Residues
Since 2020, the company has been developing a product known as 3MPD, which is produced from sugars and wood residues. According to Mevaldi, 3MPD is manufactured through a patented bio-thermochemical process and is positioned as a versatile building block suitable for a wide range of sustainable chemical applications.
Focus on Industrial Scale and Market Expansion
With the new financing, Mevaldi plans to accelerate its move toward industrial-scale production and commercialization. The company emphasizes that its entire production chain is located in Europe, allowing it to combine high performance with lower environmental impact and competitive cost structures.
Investor Perspectives
ICOS Capital highlighted Mevaldi’s potential to access multiple markets and its ability to scale production with comparatively lower capital requirements. Mevaldi CEO Roger Ottenheym stated that the investment will support the company’s goal of bringing bio-based chemical building blocks to market more rapidly, while achieving cost parity with fossil-based alternatives and reducing carbon emissions.
